CROSS COUNTRY HEALTHCARE INC (CCRN) Fundamental Analysis & Valuation

NASDAQ:CCRN • US2274831047

9.13 USD
+0.15 (+1.67%)
At close: Mar 4, 2026
8.05 USD
-1.08 (-11.83%)
After Hours: 3/4/2026, 7:31:35 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This CCRN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CCRN. CCRN was compared to 101 industry peers in the Health Care Providers & Services industry. No worries on liquidiy or solvency for CCRN as it has an excellent financial health rating, but there are worries on the profitability. CCRN is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. CCRN Profitability Analysis

1.1 Basic Checks

  • In the past year CCRN was profitable.
  • In the past year CCRN had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: CCRN reported negative net income in multiple years.
  • CCRN had a positive operating cash flow in 4 of the past 5 years.
CCRN Yearly Net Income VS EBIT VS OCF VS FCFCCRN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

1.2 Ratios

  • CCRN's Return On Assets of -2.91% is in line compared to the rest of the industry. CCRN outperforms 40.59% of its industry peers.
  • Looking at the Return On Equity, with a value of -3.84%, CCRN is in line with its industry, outperforming 49.51% of the companies in the same industry.
  • CCRN has a worse Return On Invested Capital (0.98%) than 60.40% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for CCRN is significantly above the industry average of 9.13%.
  • The last Return On Invested Capital (0.98%) for CCRN is well below the 3 year average (15.05%), which needs to be investigated, but indicates that CCRN had better years and this may not be a problem.
Industry RankSector Rank
ROA -2.91%
ROE -3.84%
ROIC 0.98%
ROA(3y)9.37%
ROA(5y)8.5%
ROE(3y)17.7%
ROE(5y)17.81%
ROIC(3y)15.05%
ROIC(5y)13.58%
CCRN Yearly ROA, ROE, ROICCCRN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

  • CCRN's Operating Margin of 0.56% is on the low side compared to the rest of the industry. CCRN is outperformed by 61.39% of its industry peers.
  • In the last couple of years the Operating Margin of CCRN has declined.
  • Looking at the Gross Margin, with a value of 20.19%, CCRN is in line with its industry, outperforming 44.55% of the companies in the same industry.
  • CCRN's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 0.56%
PM (TTM) N/A
GM 20.19%
OM growth 3Y-77.97%
OM growth 5Y-33.84%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.01%
GM growth 5Y-3.83%
CCRN Yearly Profit, Operating, Gross MarginsCCRN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. CCRN Health Analysis

2.1 Basic Checks

  • CCRN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • CCRN has less shares outstanding than it did 1 year ago.
  • CCRN has less shares outstanding than it did 5 years ago.
  • CCRN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CCRN Yearly Shares OutstandingCCRN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
CCRN Yearly Total Debt VS Total AssetsCCRN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • CCRN has an Altman-Z score of 4.49. This indicates that CCRN is financially healthy and has little risk of bankruptcy at the moment.
  • CCRN's Altman-Z score of 4.49 is fine compared to the rest of the industry. CCRN outperforms 79.21% of its industry peers.
  • There is no outstanding debt for CCRN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 4.49
ROIC/WACC0.11
WACC8.7%
CCRN Yearly LT Debt VS Equity VS FCFCCRN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

  • A Current Ratio of 3.45 indicates that CCRN has no problem at all paying its short term obligations.
  • CCRN has a better Current ratio (3.45) than 86.14% of its industry peers.
  • CCRN has a Quick Ratio of 3.45. This indicates that CCRN is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of CCRN (3.45) is better than 86.14% of its industry peers.
Industry RankSector Rank
Current Ratio 3.45
Quick Ratio 3.45
CCRN Yearly Current Assets VS Current LiabilitesCCRN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. CCRN Growth Analysis

3.1 Past

  • CCRN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -82.86%.
  • Measured over the past years, CCRN shows a very strong growth in Earnings Per Share. The EPS has been growing by 24.57% on average per year.
  • Looking at the last year, CCRN shows a very negative growth in Revenue. The Revenue has decreased by -22.14% in the last year.
  • Measured over the past years, CCRN shows a quite strong growth in Revenue. The Revenue has been growing by 10.33% on average per year.
EPS 1Y (TTM)-82.86%
EPS 3Y-47.22%
EPS 5Y24.57%
EPS Q2Q%-75%
Revenue 1Y (TTM)-22.14%
Revenue growth 3Y-7.11%
Revenue growth 5Y10.33%
Sales Q2Q%-20.65%

3.2 Future

  • CCRN is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -33.46% yearly.
  • The Revenue is expected to decrease by -7.58% on average over the next years.
EPS Next Y-76.58%
EPS Next 2Y-48.21%
EPS Next 3Y-33.46%
EPS Next 5YN/A
Revenue Next Year-20.04%
Revenue Next 2Y-13.03%
Revenue Next 3Y-7.58%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CCRN Yearly Revenue VS EstimatesCCRN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B 2.5B
CCRN Yearly EPS VS EstimatesCCRN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

3

4. CCRN Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 76.08 indicates a quite expensive valuation of CCRN.
  • CCRN's Price/Earnings is on the same level as the industry average.
  • Compared to an average S&P500 Price/Earnings ratio of 27.03, CCRN is valued quite expensively.
  • With a Price/Forward Earnings ratio of 75.64, CCRN can be considered very expensive at the moment.
  • CCRN's Price/Forward Earnings is on the same level as the industry average.
  • CCRN is valuated expensively when we compare the Price/Forward Earnings ratio to 25.11, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 76.08
Fwd PE 75.64
CCRN Price Earnings VS Forward Price EarningsCCRN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CCRN indicates a somewhat cheap valuation: CCRN is cheaper than 75.25% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, CCRN is valued cheaply inside the industry as 92.08% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 6.55
EV/EBITDA 8.26
CCRN Per share dataCCRN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • A cheap valuation may be justified as CCRN's earnings are expected to decrease with -33.46% in the coming years.
PEG (NY)N/A
PEG (5Y)3.1
EPS Next 2Y-48.21%
EPS Next 3Y-33.46%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CCRN Dividend Analysis

5.1 Amount

  • CCRN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CCRN Fundamentals: All Metrics, Ratios and Statistics

CROSS COUNTRY HEALTHCARE INC

NASDAQ:CCRN (3/4/2026, 7:31:35 PM)

After market: 8.05 -1.08 (-11.83%)

9.13

+0.15 (+1.67%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)03-04
Earnings (Next)N/A
Inst Owners96.15%
Inst Owner Change-17.21%
Ins Owners6.14%
Ins Owner Change11.51%
Market Cap299.10M
Revenue(TTM)1.13B
Net Income(TTM)-15.68M
Analysts71.43
Price Target11.6 (27.05%)
Short Float %4.29%
Short Ratio2.3
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-69.09%
Min EPS beat(2)-118.38%
Max EPS beat(2)-19.79%
EPS beat(4)1
Avg EPS beat(4)-49.67%
Min EPS beat(4)-118.38%
Max EPS beat(4)5.59%
EPS beat(8)4
Avg EPS beat(8)-23.71%
EPS beat(12)7
Avg EPS beat(12)-12.92%
EPS beat(16)11
Avg EPS beat(16)-6.6%
Revenue beat(2)0
Avg Revenue beat(2)-8.46%
Min Revenue beat(2)-9.46%
Max Revenue beat(2)-7.46%
Revenue beat(4)0
Avg Revenue beat(4)-5.87%
Min Revenue beat(4)-9.46%
Max Revenue beat(4)-0.73%
Revenue beat(8)1
Avg Revenue beat(8)-3.08%
Revenue beat(12)3
Avg Revenue beat(12)-1.76%
Revenue beat(16)6
Avg Revenue beat(16)-0.91%
PT rev (1m)-0.66%
PT rev (3m)-37.08%
EPS NQ rev (1m)-9.99%
EPS NQ rev (3m)-7.69%
EPS NY rev (1m)0%
EPS NY rev (3m)-26.19%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.14%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.04%
Valuation
Industry RankSector Rank
PE 76.08
Fwd PE 75.64
P/S 0.27
P/FCF 6.55
P/OCF 5.51
P/B 0.73
P/tB 1.26
EV/EBITDA 8.26
EPS(TTM)0.12
EY1.31%
EPS(NY)0.12
Fwd EY1.32%
FCF(TTM)1.39
FCFY15.27%
OCF(TTM)1.66
OCFY18.14%
SpS34.42
BVpS12.46
TBVpS7.25
PEG (NY)N/A
PEG (5Y)3.1
Graham Number5.8
Profitability
Industry RankSector Rank
ROA -2.91%
ROE -3.84%
ROCE 1.39%
ROIC 0.98%
ROICexc 1.26%
ROICexgc 2.43%
OM 0.56%
PM (TTM) N/A
GM 20.19%
FCFM 4.05%
ROA(3y)9.37%
ROA(5y)8.5%
ROE(3y)17.7%
ROE(5y)17.81%
ROIC(3y)15.05%
ROIC(5y)13.58%
ROICexc(3y)15.28%
ROICexc(5y)13.73%
ROICexgc(3y)22.9%
ROICexgc(5y)20.79%
ROCE(3y)21.31%
ROCE(5y)19.23%
ROICexgc growth 3Y-75.41%
ROICexgc growth 5Y-32.32%
ROICexc growth 3Y-77.25%
ROICexc growth 5Y-30.83%
OM growth 3Y-77.97%
OM growth 5Y-33.84%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.01%
GM growth 5Y-3.83%
F-Score5
Asset Turnover2.09
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 49.56%
Cap/Sales 0.76%
Interest Coverage 250
Cash Conversion 229.81%
Profit Quality N/A
Current Ratio 3.45
Quick Ratio 3.45
Altman-Z 4.49
F-Score5
WACC8.7%
ROIC/WACC0.11
Cap/Depr(3y)64.63%
Cap/Depr(5y)60.57%
Cap/Sales(3y)0.55%
Cap/Sales(5y)0.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-82.86%
EPS 3Y-47.22%
EPS 5Y24.57%
EPS Q2Q%-75%
EPS Next Y-76.58%
EPS Next 2Y-48.21%
EPS Next 3Y-33.46%
EPS Next 5YN/A
Revenue 1Y (TTM)-22.14%
Revenue growth 3Y-7.11%
Revenue growth 5Y10.33%
Sales Q2Q%-20.65%
Revenue Next Year-20.04%
Revenue Next 2Y-13.03%
Revenue Next 3Y-7.58%
Revenue Next 5YN/A
EBIT growth 1Y-52.34%
EBIT growth 3Y-79.54%
EBIT growth 5Y-27.01%
EBIT Next Year495.04%
EBIT Next 3Y80.04%
EBIT Next 5YN/A
FCF growth 1Y-79.94%
FCF growth 3YN/A
FCF growth 5Y112.02%
OCF growth 1Y-77.47%
OCF growth 3YN/A
OCF growth 5Y85.29%

CROSS COUNTRY HEALTHCARE INC / CCRN FAQ

What is the ChartMill fundamental rating of CROSS COUNTRY HEALTHCARE INC (CCRN) stock?

ChartMill assigns a fundamental rating of 5 / 10 to CCRN.


What is the valuation status for CCRN stock?

ChartMill assigns a valuation rating of 3 / 10 to CROSS COUNTRY HEALTHCARE INC (CCRN). This can be considered as Overvalued.


Can you provide the profitability details for CROSS COUNTRY HEALTHCARE INC?

CROSS COUNTRY HEALTHCARE INC (CCRN) has a profitability rating of 3 / 10.


Can you provide the expected EPS growth for CCRN stock?

The Earnings per Share (EPS) of CROSS COUNTRY HEALTHCARE INC (CCRN) is expected to decline by -76.58% in the next year.